Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Category Archives: Miscellaneous
Labeling GMO’s — Too Late and Too Much
Commentators arguing that genetically-modified plants (and animals) or “GMO’s” have been prepared by conventional plant breeding, fail to address the central issue driving the debate about the safety of genetically-engineered crops intended for human consumption. The issue is not whether … Continue reading
Posted in Miscellaneous, Uncategorized
Tagged biotechnology, biotechnology law, biotechnology news, GMO, intellectual property, ip, Patent Law, patents, Warren Woessner
Leave a comment
Patent Law Developments 2015: A Quick Recapitulation
This is a guest post from Chisum Patent Academy. Patent Law Developments 2015: A Quick Recapitulation Donald S. Chisum Co-Founder, Chisum Patent Academy In terms of case law, legislation and other developments in patent law, calendar year 2015 had no first … Continue reading
Top Patent Law Stories In 2015
I will try to keep this post as brief as possible, since I posted at length on all of the stories. There was a lot of IP action in 2015 – much involving the Fed. Cir. and Supreme Court’s resolution … Continue reading
Takeaways from Chisum’s Washington, D.C. September 2015 Seminar
On September 24-25, 2015, the Chisum Patent Academy held a two-day seminar at the offices of Kaye Scholer LLP in Washington, DC to discuss and debate current developments in U.S. patent law. The roundtable seminar group was limited to ten … Continue reading